{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:48:06Z","timestamp":1791938886236,"version":"4.3.4"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1164\/rccm.201801-0019le","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T10:50:44Z","timestamp":1530615044000},"page":"1228-1231","source":"Crossref","is-referenced-by-count":21,"title":["Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?"],"prefix":"10.1093","volume":"198","author":[{"given":"Mathieu","family":"Bastard","sequence":"first","affiliation":[{"name":"Epicentre, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Guglielmetti","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res, Paris, France"},{"name":"H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France"},{"name":"Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Huerga","sequence":"additional","affiliation":[{"name":"Epicentre, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen","family":"Hayrapetyan","sequence":"additional","affiliation":[{"name":"National Tuberculosis Control Centre of Armenia, Yerevan, Armenia, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira","family":"Khachatryan","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res, Yerevan, Armenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Yegiazaryan","sequence":"additional","affiliation":[{"name":"National Tuberculosis Control Centre of Armenia, Yerevan, Armenia, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Faqirzai","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res, Yerevan, Armenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Hovhannisyan","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res, Yerevan, Armenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Varaine","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hewison","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"2026032023270270600_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5588\/ijtld.15.0962","article-title":"Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study","volume":"20","author":"Bonnet","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026032023270270600_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa1604544","article-title":"Transmission of extensively drug-resistant tuberculosis in South Africa","volume":"376","author":"Shah","year":"2017","journal-title":"N Engl J Med"},{"key":"2026032023270270600_bib3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMoa1313865","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline","volume":"371","author":"Diacon","year":"2014","journal-title":"N Engl J Med"},{"key":"2026032023270270600_bib4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1183\/09031936.00125812","article-title":"Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis","volume":"41","author":"Skripconoka","year":"2013","journal-title":"Eur Respir J"},{"key":"2026032023270270600_bib5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/jis460","article-title":"World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?","volume":"207","author":"Dooley","year":"2013","journal-title":"J Infect Dis"},{"key":"2026032023270270600_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1183\/09031936.00035114","article-title":"Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China","volume":"45","author":"Tang","year":"2015","journal-title":"Eur Respir J"},{"key":"2026032023270270600_bib7","article-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis;","author":"World Health Organization","year":"2014 [ 2017  30]"},{"key":"2026032023270270600_bib8","doi-asserted-by":"crossref","first-page":"1601799","DOI":"10.1183\/13993003.01799-2016","article-title":"Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis","volume":"49","author":"Guglielmetti","year":"2017","journal-title":"Eur Respir J"},{"key":"2026032023270270600_bib9","doi-asserted-by":"crossref","first-page":"1701105","DOI":"10.1183\/13993003.01105-2017","article-title":"Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens","volume":"50","author":"Kuksa","year":"2017","journal-title":"Eur Respir J"},{"key":"2026032023270270600_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5588\/ijtld.17.0706","article-title":"Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis","volume":"22","author":"Cox","year":"2018","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/198\/9\/1228\/67120254\/ajrccm_198_9_1228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/198\/9\/1228\/67120254\/ajrccm_198_9_1228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:28:12Z","timestamp":1774063692000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/198\/9\/1228\/8498367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":10,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,11,1]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201801-0019le","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,11,1]]}}}